Log in to save to my catalogue

Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with s...

Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6249529

Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography

About this item

Full title

Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography

Author / Creator

Publisher

Turkey: Kare Publishing

Journal title

Anatolian journal of cardiology, 2018-10, Vol.20 (4), p.213-219

Language

English

Formats

Publication information

Publisher

Turkey: Kare Publishing

More information

Scope and Contents

Contents

Parkinson's disease (PD) is a neurological disorder, and ergot dopamine agonists (DAs) are no longer usually preferred in the treatment due to the increased risk of valvular heart disease. Some recent studies have shown that commonly used non-ergot DA also increases the risk of heart failure. On the other hand, there are studies showing conflicting...

Alternative Titles

Full title

Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6249529

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6249529

Other Identifiers

ISSN

2149-2263

E-ISSN

2149-2271

DOI

10.14744/AnatolJCardiol.2018.65983

How to access this item